Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 28 of about 42 companies and 8 funds for Stephen Dean�
Company Exchange Symbol Last price Quote change Market cap
Wells Fargo & Co NYSE WFC 51.87 +0.18 (0.35%) 269.84B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
ImmunoGen, Inc. NASDAQ IMGN 10.59 -0.58 (-5.19%) 959.59M
ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for the treatment of cancer. ImmunoGen designs linkers that enable antibody-based ...
Executive:
Stephen C. McCluski.
Tyson Foods, Inc. NYSE TSN 39.37 +0.52 (1.34%) 14.59B
Tyson Foods, Inc. is a food production company. The Company produces, distributes and markets chicken, beef, pork, prepared foods and related allied ...
Executive:
Stephen R. Stouffer
Wells Fargo & Co OTCMKTS WFCNP 0.570 0.000 (0.00%) 269.84B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
Wells Fargo & Co NYSE WFC-L 1,202.51 -0.49 (-0.04%) 269.84B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
Pengrowth Energy Corp (USA) NYSE PGH 5.20 -0.12 (-2.26%) 2.81B
Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves ...
Executive:
Stephen J.
Abraxas Petroleum Corp. NASDAQ AXAS 5.28 -0.23 (-4.17%) 580.67M
Abraxas Petroleum Corporation is an independent energy company primarily engaged in the acquisition, exploitation, development and production of oil and gas ...
Executive:
Stephen T.
WaferGen Bio-systems, Inc. NASDAQ WGBS 4.35 -0.05 (-1.14%) 4.11M
WaferGen Bio-systems, Inc. (WBSI) is engaged in the development, manufacture and marketing of laboratory analytical instruments for cell biology, ...
Executive:
Joel Stephen Kanter
Plexus Corp. NASDAQ PLXS 36.93 -0.89 (-2.35%) 1.28B
Plexus Corp. (Plexus) and its subsidiaries deliver solutions to its customers through its Product Realization Value Stream. The Company's customer-focused ...
Executive:
Stephen P. Cortinovis
Alexandria Real Estate Equities Inc NYSE ARE 73.75 -0.83 (-1.11%) 5.35B
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company is an owner and REIT, and life science real estate company, ...
Executive:
Stephen A.
Transfield Services Limited ASX TSE 1.51 +0.03 (2.02%) 766.09M
Transfield Services Limited is engaged in the provision of operations and maintenance, asset management, project and capital management outsourcing and ...
Executive:
Stephen Philips
Boulder Brands Inc NASDAQ BDBD 13.63 +0.03 (0.26%) 829.36M
Boulder Brands, Inc. is a supplier of gluten-free and health and wellness products in the United States and Canada. The Company distributes its products in ...
Executive:
Stephen B. Hughes
Diamcor Mining Inc. CVE DMI 1.37 0.00 (0.00%) 51.98M
Diamcor Mining Inc. is a junior mining and exploration company. The Company principal business is the identification, acquisition, exploration, evaluation, ...
Executive:
Stephen E. Haggerty.
Navigant Consulting, Inc. NYSE NCI 13.91 -0.21 (-1.49%) 689.61M
Navigant Consulting, Inc. is an independent specialty consulting firm. Professional services include dispute, investigative, economic, operational, ...
Landec Corporation NASDAQ LNDC 12.25 -0.10 (-0.81%) 331.50M
Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed ...
Executive:
Stephen E. Halprin
REGAL-BELOIT CORPORATION NYSE RBC 64.25 -1.25 (-1.91%) 2.96B
Regal Beloit Corporation is a global manufacturer of electric motors and controls, electric generators and controls, and mechanical motion control products.
Executive:
Stephen M.
Cytomedix, Inc. OTCMKTS CMXI 0.400 +0.009 (2.25%) 49.75M
Cytomedix, Inc. (Cytomedix) is a regenerative therapies company marketing and developing products within the United States and internationally .
Executive:
Stephen N. Keith MD
Canadian Tire Corporation Limited TSE CTC.A 114.75 +1.65 (1.46%) 9.34B
Canadian Tire Corporation, Limited comprises two main business operations that offer a range of retail goods and services, including general merchandise, ...
Executive:
Stephen G. Wetmore.
Sherritt International Corporation TSE S 3.10 -0.39 (-11.17%) 921.63M
Sherritt International Corporation (Sherritt) is a Canada-based natural resource company, which operates in Canada and Cuba. The Company, through its ...
Executive:
Harold S. Stephen
Boulder Growth & Income Fund Inc NYSE BIF 8.84 +0.02 (0.22%) 224.64M
Boulder Growth & Income Fund, Inc. (the Fund) is a non-diversified, closed-end management company. The Fund's investment objective is total return.
Executive:
Stephen C. Miller Esq.
Show all 42 companies »
Mutual Fund Symbol Nav Nav change
CI Cambridge Canadian Growth Companies Fund Class A CIG11108 20.48 -0.06 (-0.29%)
The fundamental investment objective of Cambridge Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity Fund Class A CIG11109 21.85 0.00 (0.00%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity Fund Class AT6 CIG11609 26.79 0.00 (0.00%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class B CIG11208 16.61 0.00 (0.00%)
The fundamental investment objective of Castlerock Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class BT6 CIG11708 21.88 0.00 (0.00%)
The fundamental investment objective of Castlerock Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class AT6 CIG11608 25.04 -0.07 (-0.28%)
The fundamental investment objective of Cambridge Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity O CIG18158 12.85 0.00 (0.00%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity E CIG16158 12.81 0.00 (0.00%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.